When is serum (or plasma) ammonia measurement preferred over whole‑blood ammonia for clinical assessment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Plasma (Serum) Ammonia is Preferred Over Whole Blood for Clinical Assessment

Plasma or serum ammonia measurement is the standard and preferred specimen type for clinical assessment of hepatic encephalopathy and hyperammonemia, as it provides more accurate and reliable results than whole blood measurements.

Why Plasma/Serum is Preferred

The key distinction lies in cellular ammonia contribution. Whole blood contains ammonia from both plasma and cellular components (red blood cells, white blood cells, platelets), which can artificially elevate results 1, 2. Research demonstrates that:

  • Plasma samples yield higher ammonia concentrations than whole blood due to the exclusion of cellular interference 1
  • The increase in blood ammonia over time is predominantly of cellular origin 2
  • Each sample type requires specimen- and method-specific reference intervals for proper interpretation 1

Clinical Context from Guidelines

Major hepatology guidelines frame ammonia measurement specifically in terms of plasma ammonia 3:

  • The EASL 2022 guidelines explicitly recommend "plasma ammonia measurement" in patients with delirium/encephalopathy and liver disease 3
  • A normal plasma ammonia level has high negative predictive value - it should prompt investigation for other causes of altered mental status 4, 3
  • However, routine ammonia testing is NOT recommended for diagnosis in all patients with cirrhosis and altered mental status 4

When to Measure Ammonia

Ammonia measurement is most valuable:

  • In acute encephalopathy with liver disease to rule out hepatic encephalopathy if normal 3
  • In pediatric/neonatal settings for inherited metabolic disorders 5
  • First episode of altered mental status in cirrhosis patients 4
  • When patients don't respond to empirical HE therapy 4

Practical Laboratory Considerations

Anticoagulant Choice

EDTA-anticoagulated plasma is the most reliable specimen 6, 7:

  • EDTA tubes are widely used (78% of laboratories) 7
  • Heparin-anticoagulated plasma shows substantially less precision 6
  • Oxalate plasma has higher baseline apparent ammonia due to interferants 6

Sample Handling - Important Update

Recent evidence challenges traditional ice transport requirements 2, 8:

  • Blood samples for ammonia do not require ice transport if analyzed within 2 hours 2
  • Ice transport can actually increase hemolysis index without improving stability 2
  • The ammonia increase over 2 hours at room temperature is below clinically significant thresholds 2, 8
  • Laboratories should accept samples not collected under "ideal" conditions to avoid delayed diagnosis 8, 9

Critical Pitfall

Despite updated MetBio.net guidelines, many laboratories still reject samples that are "too old" (64%), hemolyzed (72%), or not sent on ice (24%) 9. This practice can delay diagnosis and treatment of life-threatening hyperammonemia 9.

Point-of-Care Considerations

While point-of-care ammonia meters can use whole blood for rapid assessment 1, 10, results must be interpreted using whole blood-specific reference ranges, not plasma ranges. The enzymatic glutamate dehydrogenase (GLDH) method remains the predominant laboratory standard (97.6% of laboratories) 7.

Clinical Bottom Line

Use EDTA-anticoagulated plasma for ammonia measurement, process within 2 hours (ice not required), and remember that ammonia testing is most valuable for its negative predictive value in ruling out hepatic encephalopathy rather than confirming it 3. Laboratories should accept all samples to prevent dangerous delays in hyperammonemia management 8, 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.